Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Peptide Sciences is a premier provider of high-purity research peptides, proteins, and amino acid derivatives based in the United States. The company focuses on the synthesis of complex peptides for laboratory research and development, maintaining a vast catalog that includes growth hormone secretagogues, metabolic regulators, and tissue repair factors. Their manufacturing process utilizes advanced solid-phase peptide synthesis (SPPS) techniques to ensure purity levels exceeding 99 percent. While their products are utilized globally by the scientific community, they are strictly marketed for in-vitro laboratory research and are not intended for therapeutic or diagnostic use in humans or animals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Peptide Sciences.